Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
Platelets Journal shared a post on LinkedIn about a recent article by Fumiya Wada et al, published in Platelets, adding:
“Recently published in Platelets!
‘Durable platelet response and immature platelet indices following sequential efgartigimod and eltrombopag therapy in a patient with refractory ITP’ by Fumiya Wada, et al. (2026).
This case report follows a 53-year-old woman with refractory immune thrombocytopenia (ITP) who had cycled through numerous therapies without lasting benefit.
Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, produced a partial response and when supplemented with the TPO-RA eltrombopag, the combination contributed to a sustained response.
Remarkably, after stopping efgartigimod at 22 weeks, remission continued for a further 24 weeks on eltrombopag alone.
The authors also tracked immature platelet indices throughout, observing a reciprocal shift, with IPF percent falling while AIPF rose, mirroring recovering platelet counts (see Figure 2, below).
This suggests that combining IgG depletion with enhanced platelet production may act synergistically in ITP, and these indices might serve as practical biomarkers for monitoring treatment response.”
Title: Durable platelet response and immature platelet indices following sequential efgartigimod and eltrombopag therapy in a patient with refractory ITP
Authors: Fumiya Wada, Hiroyuki Matsui, Takuji Nakamura, Tomomi Satoh-Nakamura, Yutaka Shinkawa, Hisanori Umehara, Akifumi Takaori-Kondo
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026